President Donald Trump is expected to announce a deal with Pfizer on Tuesday as part of his “Most Favored Nation” initiative ...

Key Takeaways FDA has launched an aggressive new crackdown on direct-to-consumer (DTC) drug advertising, issuing nearly 100 cease-and-desist letters and thousands of notices — many targeting ...

While the recent plan to crack down on DTC drug ads won't make much of an impact, we agree with the Trump administration that ...

A spokesperson for the Denver Police Department told CBS News Colorado that the ad campaign has had no effect on staffing ...

Federal health officials are cracking down on telehealth companies’ promotion of unapproved versions of prescription drugs.

We have been complaining about direct-to-consumer (DTC) prescription drug advertising for decades. Far too often, the commercials make it seem as if their products are magical. People are seen ...

Legal and regulatory experts expect litigation to arise if the FDA seeks to enforce its pharma DTC ad crackdown, though how it might play out is nuanced.

The FDA asserted that the 90-second TV ad misbrands Novartis’ Fabhalta and makes the distribution of the drug in violation of the Federal Food, Drug, and Cosmetic Act.

Commentary: Americans are among the few people in the world bombarded with advertisements for medications most of us don’t ...

Opinion: Lawsuit ads warning about prescription drugs or medical devices generate fear that can put patients at risk.